Purification Of Iduronate-2-Sulfatase

Patent No. EP2867245 (titled "Purification Of Iduronate-2-Sulfatase") was filed by Shire Human Genetic Therapies on Jun 28, 2013. The application was issued on Sep 12, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HGFJun 12, 2019HGF

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2867245

SHIRE HUMAN GENETIC THERAPIES
Application Number
EP13809853A
Filing Date
Jun 28, 2013
Status
Revoked
Jun 24, 2024
Publication Date
Sep 12, 2018